National Health Investors (NYSE:NHI) Announces Quarterly Earnings Results, Misses Estimates By $0.42 EPS

National Health Investors (NYSE:NHI) announced its quarterly earnings results on Tuesday. The real estate investment trust reported $0.65 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.42), Zacks reports. National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The company had revenue of $63.32 million for the quarter, compared to analyst estimates of $67.93 million. During the same period in the prior year, the business posted $1.08 earnings per share. National Health Investors’s revenue for the quarter was up 1.7% on a year-over-year basis. National Health Investors updated its FY24 guidance to $4.43-$4.44 EPS and its FY 2024 guidance to 4.430-4.440 EPS.

National Health Investors Trading Up 3.8 %

NHI traded up $2.88 during midday trading on Thursday, hitting $79.64. The company’s stock had a trading volume of 451,097 shares, compared to its average volume of 194,790. The firm has a market cap of $3.46 billion, a P/E ratio of 27.07, a PEG ratio of 5.05 and a beta of 1.05. National Health Investors has a 52-week low of $49.25 and a 52-week high of $86.13. The company has a current ratio of 10.27, a quick ratio of 10.27 and a debt-to-equity ratio of 0.91. The firm has a 50-day moving average price of $80.38 and a two-hundred day moving average price of $73.16.

National Health Investors Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Shareholders of record on Tuesday, December 31st will be paid a $0.90 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 annualized dividend and a yield of 4.52%. National Health Investors’s payout ratio is currently 122.45%.

Analysts Set New Price Targets

A number of brokerages recently weighed in on NHI. Truist Financial raised their price target on shares of National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a research note on Friday, August 30th. StockNews.com cut National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, October 15th. Wells Fargo & Company cut shares of National Health Investors from an “overweight” rating to an “equal weight” rating and increased their price objective for the stock from $81.00 to $86.00 in a research report on Tuesday, October 1st. Finally, Bank of America initiated coverage on shares of National Health Investors in a research report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price target on the stock. Four investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, National Health Investors currently has a consensus rating of “Moderate Buy” and a consensus price target of $73.29.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.